financetom
Business
financetom
/
Business
/
Sensient Technologies Q2 Adjusted Earnings Fall, Revenue Rises; Revises 2024 Outlook
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Sensient Technologies Q2 Adjusted Earnings Fall, Revenue Rises; Revises 2024 Outlook
Jul 26, 2024 5:22 AM

07:54 AM EDT, 07/26/2024 (MT Newswires) -- Sensient Technologies ( SXT ) reported Q2 adjusted earnings Friday of $0.77 per diluted share, down from $0.81 a year earlier.

Analysts polled by Capital IQ expected $0.82.

Revenue for the quarter ended June 30 was $403.5 million, up from $374.3 million a year earlier.

Analysts surveyed by Capital IQ expected $398 million.

The manufacturer of specialty ingredients said it now expects full-year 2024 adjusted diluted EPS to grow at mid-single-digit compared with low to mid-single-digit growth previously. Analysts polled by Capital IQ expect $3.03.

Revenue for the year is now expected to increase at a mid- to high-single-digit rate, compared with mid-single-digit growth previously anticipated, the company said. Analysts surveyed by Capital IQ expect $1.53 billion.

Price: 80.60, Change: +0.02, Percent Change: +0.02

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Market Chatter: Trump to Announce Deal With Eli Lilly, Novo Nordisk on Weight Loss Drugs Thursday
Market Chatter: Trump to Announce Deal With Eli Lilly, Novo Nordisk on Weight Loss Drugs Thursday
Nov 5, 2025
01:26 PM EST, 11/05/2025 (MT Newswires) -- President Donald Trump is scheduled to announce at 11 a.m. Thursday a deal with Eli Lilly ( LLY ) and Novo Nordisk ( NVO ) on the price of weight loss medications, CBS News reporter Jennifer Jacobs said on X. The deal is expected to lower the drug price to under $150 per...
AbbVie, Ironwood Win FDA Approval for Linzess to Treat Children With Irritable Bowel Syndrome With Constipation
AbbVie, Ironwood Win FDA Approval for Linzess to Treat Children With Irritable Bowel Syndrome With Constipation
Nov 5, 2025
01:01 PM EST, 11/05/2025 (MT Newswires) -- AbbVie ( ABBV ) and Ironwood Pharmaceuticals ( IRWD ) received US Food and Drug Administration approval for Linzess (linaclotide) to treat children aged seven years and older with irritable bowel syndrome with constipation. The approval, the first therapy cleared for pediatric patients with the condition, was based on data from adult studies...
Starbucks workers union vote to authorize strike amid stalled talks
Starbucks workers union vote to authorize strike amid stalled talks
Nov 5, 2025
Nov 5 (Reuters) - Unionized Starbucks ( SBUX ) baristas voted to authorize an open-ended strike ahead of Starbucks' ( SBUX ) high-traffic holiday season, announced Starbucks Workers United on Wednesday. The union said workers are prepared to strike if a contract is not finalized by November 13, which is the company's Red Cup Day, and strike actions could hit...
ConnectM Acquires Geo Impex, Securing Regulatory-Approved Site for AI-Driven Data Center and Multimodal Logistics Park Development
ConnectM Acquires Geo Impex, Securing Regulatory-Approved Site for AI-Driven Data Center and Multimodal Logistics Park Development
Nov 5, 2025
MARLBOROUGH, Mass., Nov. 05, 2025 (GLOBE NEWSWIRE) -- ConnectM Technology Solutions, Inc. ( CNTM ) (“ConnectM” or the “Company”), a high-growth technology company powering the modern energy economy, today announced the acquisition of Geo Impex & Logistics Private Limited (“Geo Impex”), an India-based developer of sustainable logistics infrastructure. The transaction grants ConnectM and its subsidiary Keen Labs (www.keenlabs.ai) ownership of...
Copyright 2023-2026 - www.financetom.com All Rights Reserved